Retatrutide – 15mg Vial

Retatrutide is a cutting-edge investigational peptide developed as a multi-receptor agonist that targets GLP-1, GIP, and glucagon receptors. Early research suggests it may play a powerful role in:

• Regulating blood sugar

• Supporting weight loss and fat reduction

• Enhancing metabolic health

• Promoting improved insulin sensitivity

As a triple-agonist peptide, Retatrutide represents the next step forward in metabolic research, offering broader benefits compared to semaglutide or tirzepatide.

Key Features

• 10mg lyophilized peptide vial

• ≥99% purity, third-party tested

• Triple receptor agonist: GLP-1, GIP, Glucagon

• Research focus: metabolic health & weight management

• Storage: 2–8°C (refrigerate after reconstitution)

Research Applications

• Advanced weight management research

• Glucose regulation studies

• Insulin sensitivity improvement

• Metabolic and obesity-related research

Disclaimer

This product is strictly intended for laboratory research purposes. Not for human or animal consumption.